Page 8 - Ankit Bhargava News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genelux (GNLX) Announces Publication of Positive Topline Data from Phase 2 VIRO-15 Trial

Genelux (GNLX) Announces Publication of Positive Topline Data from Phase 2 VIRO-15 Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Robertw hollowayOlvimulogene nanivacirepvecOlvimulogene nanivacirepvec olvi vecJack westAnkit bhargavaThomas zindrickSecurities exchangeGenelux corporationAllele communicationsGynecologic oncology program at adventhealth cancer instituteExchange commissionOriginal investigationDisease control rateMedical directorGynecologic oncology programAdventhealth cancer institute

Genelux Corp (GNLX) Prices 2 5M Share IPO at $6/sh, Top of Range

Genelux Corp (GNLX) Prices 2 5M Share IPO at $6/sh, Top of Range
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMichael fontaineAnkit bhargavaExchange commissionProspectus departmentMdallele communicationsArcadia securitiesGenelux corporationWall streetNasdaq capital marketBenchmark companyBrookline capital marketsRisk factors

Genelux Corporation Announces Pricing of Initial Public Offering

Genelux Corporation Announces Pricing of Initial Public Offering
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMichael fontaineAnkit bhargavaExchange commissionProspectus departmentArcadia securitiesGenelux corporationAllele communicationsNasdaq capital marketBenchmark companyBrookline capital marketsRisk factors

Matinas BioPharma Announces Collaboration with National Resilience to Explore and Evaluate Novel LNC Platform Delivery Technology for Certain Nucleic Acids

Matinas BioPharma Announces Collaboration with National Resilience to Explore and Evaluate Novel LNC Platform Delivery Technology for Certain Nucleic Acids
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Matinas biopharmaJeromed jabbourAnkit bhargavaMatinas biopharma holdings incNational resilience incMd allele communicationsNational resilienceMaterial transferEvaluation agreementChief executive officerPrivate securities litigation reform actMatinas biopharma holdingsMedia contacts

Matinas BioPharma Announces Infectious Diseases Society of America (IDSA) has Selected the EnACT Phase 2 Trial Abstract of MAT2203 as its Outstanding Abstract and IDSA Awardee For IDWeek 2022

Matinas BioPharma Announces Infectious Diseases Society of America (IDSA) has Selected the EnACT Phase 2 Trial Abstract of MAT2203 as its Outstanding Abstract and IDSA Awardee For IDWeek 2022
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesMatinas biopharmaDavidr boulwareJeromed jabbourMucunguzi atukundaAnkit bhargavaMatinas biopharma holdings incMedicine associationUniversity of minnesota antifungal clinical trialsGilead sciencesSociety for healthcare epidemiology of americaNational institutes of healthAllele communicationsPediatric infectious diseases societyWaltere washington convention centerInfectious disease institute